Alzheimer's Blood Test Wins FDA Nod for Primary Care Use

The FDA has cleared a blood test for early Alzheimer's detection for use in primary care settings, a major diagnostic milestone.

The test could dramatically expand access to early interventions and reduce reliance on expensive PET scans.

Medicare is reviewing coverage policies as adoption begins nationwide.